NAGE NASDAQ
Niagen Bioscience Inc
1W: -0.3%
1M: -24.5%
3M: -22.0%
YTD: -39.4%
1Y: -64.8%
3Y: +152.7%
5Y: -45.1%
$3.66
-0.13 (-3.43%)
Weekly Expected Move ±10.2%
$3
$3
$4
$4
$4
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$291.5M
52W Range3.57-14.69
Volume720,142
Avg Volume1,218,795
Beta2.17
Dividend—
Analyst Ratings
Company Info
CEORobert N. Fried
Employees104
SectorHealthcare
IndustryBiotechnology
IPO Date2015-06-24
Websiteniagenbioscience.com
10900 Wilshire Blvd, Suite 600
Los Angeles, CA 90024
US
Los Angeles, CA 90024
US
310 388 6706
About Niagen Bioscience Inc
Niagen Bioscience Inc is a bioscience company dedicated to healthy aging. The Company leads research on nicotinamide adenine dinucleotide.
Latest News
Snap, Whirlpool, Nerdwallet And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Niagen Bioscience reaffirms 10%-15% 2026 growth outlook while increasing marketing spend expectations
Niagen Bioscience (NAGE) Q1 Earnings and Revenues Top Estimates
Niagen (NAGE) Q1 2026 Earnings Call Transcript
Earnings Scheduled For May 6, 2026
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Fried Robert N | M-Exempt | 20,000 | $2.61 | 2026-04-24 |
| Fried Robert N | M-Exempt | 20,000 | $2.61 | 2026-04-24 |
| Lopez Carlos Luis | A-Award | 41,420 | $4.94 | 2026-02-19 |
| Pamir Ozan | A-Award | 62,131 | $4.94 | 2026-02-19 |
| Fried Robert N | A-Award | 503,937 | $4.94 | 2026-02-19 |